Testing robot-assisted vs standard surgery for resectable esophageal cancer
Part of Cancer, Digestive system clinical trials.
This trial compares a robot-assisted approach to a standard minimally invasive approach for surgery in people with certain types of esophageal or gastroesophageal junction cancer that can be removed. It aims to see which surgery method works better and is safer for these patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a specific cancer type: adenocarcinoma in the esophagus or the gastroesophageal junction.
- Your cancer can be fully removed with surgery (it has not spread to distant organs).
- Your tumor location must match types Siewert I or II, not type III.
- You are between 18 and 90 years old.
- Your overall health/activity level is good enough for study surgery (ECOG 0, 1, or 2).
- You agree to participate by signing an informed consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares robot-assisted surgery with the standard open chest operation to remove esophagus and nearby tissue. It may help you understand which approach works better and is safer for patients whose cancer can be surgically removed.
This trial compares two different surgical approaches for people with esophageal cancer who have already received treatment like chemo or radiation before surgery. It aims to see which method works better and is safer.
This study tests a new robotic surgery system for a specific type of stomach-adjacent cancer. The goal is to see if the robotic approach is safe and effective in removing the tumor.
This trial compares two types of minimally invasive surgery for esophageal cancer to see which is better. It is for people whose cancer can be removed with surgery and who are healthy enough for either approach.
This trial tests a new robotic approach to remove the esophagus in people with early to mid-stage esophageal cancer. It aims to see if robotic surgery is safe and effective.
This phase 3 trial compares robot-assisted surgery to standard laparoscopic surgery for treating stomach cancer that has grown through the stomach wall (cT4a) but not spread to distant organs. The goal is to see which approach may offer better outcomes.
Hear when a new Esophageal Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.